Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Rohan K. Achar
Observed name:
Rohan Achar
Institutions:
Yale Cancer Center,
Yale University
Observed institutions:
Rush University Medical Center,
Duke University,
University of Michigan,
Hospital of the University of Pennsylvania,
Yale Cancer Center,
Yale University,
VA Ann Arbor Healthcare System,
Michigan Medicine,
Michigan Center for Translational Pathology,
Rush University
show all 10
ORCID:
0000-0003-0077-7103
Observed ORCID:
0000-0003-0077-7103
OpenAlex ID:
A5087636613
Liver metastasis restrains immunotherapy efficacy via macrophage-mediated T cell elimination
2021
·
Jiali Yu
, Michael D. Green
, et al.
·
Nature Medicine
·
1,001
Architectural Modification of Conformal PEG‐Bottlebrush Coatings Minimizes Anti‐PEG Antigenicity While Preserving Stealth Properties
2019
·
Daniel Y. Joh
, Zackary Zimmers
, et al.
·
Advanced Healthcare Materials
·
97
Inkjet-printed point-of-care immunoassay on a nanoscale polymer brush enables subpicomolar detection of analytes in blood
2017
·
Daniel Y. Joh
, Angus M. Hucknall
, et al.
·
Proceedings of the National Academy of Sciences
·
89
Poly(oligo(ethylene glycol) methyl ether methacrylate) Brushes on High-κ Metal Oxide Dielectric Surfaces for Bioelectrical Environments
2017
·
Daniel Y. Joh
, Felicia McGuire
, et al.
·
ACS Applied Materials & Interfaces
·
31
MiPanda: A Resource for Analyzing and Visualizing Next-Generation Sequencing Transcriptomics Data
2018
·
Yashar S. Niknafs
, Balaji Pandian
, et al.
·
Neoplasia
·
21
PDF
Engineering the Surface Properties of a Zwitterionic Polymer Brush to Enable the Simple Fabrication of Inkjet-Printed Point-of-Care Immunoassays
2018
·
Cassio M. Fontes
, Rohan K. Achar
, et al.
·
Langmuir
·
17
Correction: Individual Case Analysis of Postmortem Interval Time on Brain Tissue Preservation
2016
·
Jeffrey A. Blair
, Chunyu Wang
, et al.
·
PLoS ONE
·
15
PDF
Real‐world outcomes of intensive induction approaches in core binding factor acute myeloid leukemia
2024
·
Alexandra E. Rojek
, Benjamin J. McCormick
, et al.
·
eJHaem
·
10
PDF
Development and external validation of a machine learning model for prediction of survival in extremity leiomyosarcoma
2024
·
Austin Yu
, Linus Lee
, et al.
·
Surgical Oncology
·
4
Real‐World Outcomes of Relapsed/Refractory Core‐Binding Factor Acute Myeloid Leukemia: A COMMAND Registry Study
2025
·
Alexandra E. Rojek
, Benjamin J. McCormick
, et al.
·
American Journal of Hematology
·
1
ICE-T: Iron Clinical Evaluation Tool - a Digital Platform for Guideline-Based Iron Study Interpretation and Treatment Recommendations
2024
·
Rohan Achar
, Katherine J Feder
, et al.
·
Blood
·
1
Outcomes of patients with acute myeloid leukemia treated with intensive therapy after failure of venetoclax-inclusive, less-intensive therapy
2024
·
Rohan K. Achar
, Benjamin J. McCormick
, et al.
·
Leukemia Research
·
1
Treatment Patterns Among Patients with Relapsed/Refractory Core-Binding Factor Acute Myeloid Leukemia after Intensive Induction Chemotherapy
2023
·
Alexandra E. Rojek
, Benjamin J. McCormick
, et al.
·
Blood
·
1
PDF
Comparison of 2 penicillin allergy skin test referral strategies
2023
·
Rohan K. Achar
, Siddharth Madapoosi
, et al.
·
The Journal of Allergy and Clinical Immunology In Practice
·
1
Cardiovascular Events in Patients With Acute Myeloid Leukemia Treated With Venetoclax
2026
·
Sabin Filimon
, Azin Ghamari
, et al.
·
JACC Advances
Current landscape and future directions for treatment of accelerated-phase and blast-phase myeloproliferative neoplasms
2026
·
Rohan K. Achar
, Jan Philipp Bewersdorf
·
Seminars in Hematology
Cardiovascular Events in Patients With Acute Myeloid Leukemia Treated With Venetoclax: a Multicenter Study
2025
·
Sabin Filimon
, Azin Ghamari
, et al.
·
Journal of the American College of Cardiology
PDF
Intensive Induction Chemotherapy with or without Gemtuzumab Ozogamicin Among Patients with Core-Binding Factor Acute Myeloid Leukemia
2023
·
Alexandra E. Rojek
, Benjamin J. McCormick
, et al.
·
Blood
PDF
Outcomes of Patients Receiving Intensive Therapy for Acute Myeloid Leukemia Relapsed after/Refractory to Frontline Less-Intensive Therapy
2023
·
Rohan Achar
, Benjamin J. McCormick
, et al.
·
Blood
PDF
Comparison of two strategies for increasing primary care referral for penicillin allergy testing
2022
·
Rohan Achar
, Danielle Devlin
, et al.
·
Journal of Allergy and Clinical Immunology
76865 Clinical Outcomes of Chronic Myelomonocytic Leukemia in the VA Healthcare System
2021
·
Rohan Achar
, Talha Anwar
, et al.
·
Journal of Clinical and Translational Science
PDF
Show more works
View as search
Works count:
21
Citation count:
1,288
H-index:
8
I10-index:
8
Year
Topic
Type